Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0015695 (fatty liver)
 13,941 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

31P-MR-Spectroscopy was performed in 28 patients with focal (n = 23) and diffuse (n = 5) liver disease and in 18 healthy volunteers. The spectra were obtained with a whole body scanner operating at 1.5 T by using a surface coil. To get T1-weighted 31P-spectra a short TR of 600 msec was taken, because T1-weighted spectra of focal liver disease were more significantly different from spectra from healthy volunteers than density weighted ones. The VOI from patients with focal superficial alterations showed a mean volume of 172 ml, with diffuse liver disease 196 ml, and from volunteers 158 ml. Focal tumors filled up the VOI on an average of 70%. This investigation demonstrated that PME/beta-ATP- and PDE/beta-ATP-ratios were sensitive indicators for focal liver disease. As a result of this study we could establish a significant increase of PME/beta-ATP- (0.75 +/- 0.30) and PDE/beta-ATP-ratios (1.68 +/- 0.62) in patients with superficial focal liver metastases (n = 19) compared to the control group (PME/beta-ATP: 0.49 +/- 0.17, PDE/beta-ATP: 1.24 +/- 0.24; t-test: p < 0.02). Patients with a hemangioma (n = 1), liver infarction (n = 1), empyema of gallbladder (n = 1) and a hepatic involvement by a malignant lymphoma (n = 1) showed a similar increase of PME/beta-ATP and/or PDE/beta-ATP. Up to now spectral changes seemed to be non-specific. The ratios of 31P metabolites of the cirrhoses (n = 4) and the fatty liver (n = 1) did not show any characteristic changes versus the volunteers.
 ...
PMID:A study of T1-weighted 31phosphorus MR-spectroscopy from patients with focal and diffuse liver disease. 146 Oct 92

To assess the utility of changes in the volume of the caudate lobe in the sonographic diagnosis of liver cirrhosis, the authors studied 58 patients with histologically proved cirrhosis, 18 patients with fatty liver, 28 patients with liver metastases, seven patients with lymphomatous liver involvement, and 75 healthy individuals. The longitudinal (CL), transverse (CT), and anteroposterior (CAP) diameters of the caudate lobe and the transverse diameter of the right lobe (RL) were measured, and one-, two-, and three-dimensional caudate lobe indexes and ratios were calculated. The analysis of the diagnostic performance of these criteria, compared by means of receiver-operating characteristic curves, revealed that the ratio of the three-dimensional caudate index (CI3) to the right lobe diameter (CI3/RL = [CL X CT X CAP]/RL) was superior to all other calculated criteria. At a specificity of 95%, the sensitivity of CI3/RL was 94.7%, compared with 73.3% for CT/RL. No significant differences were found between the control group and patients with fatty liver, metastases, or lymphomatous involvement. The study suggests that CI3/RL is the most reliable quantitative criterion for the US diagnosis of liver cirrhosis.
 ...
PMID:Diagnosis of liver cirrhosis with US: receiver-operating characteristic analysis of multidimensional caudate lobe indexes. 264 15

Two investigators were asked to evaluate independently the echogenicity, coarsening and inhomogeneity of the hepatic echo pattern in a semi-quantitative manner; they had no knowledge of the diagnosis and used the same apparatus. The three subjective criteria were largely independent from the observer. Approximately three-quarters of all patients with slightly increased echogenicity showed a subjective appearance of coarsening; the impression of inhomogeneity increased significantly with increasing echogenicity. This is of importance in the sonographic evaluation of cirrhosis of the liver and in the diagnosis of diffuse liver metastases in a fatty liver. Grey scale analysis within a region of interest showed satisfactory correlation between the measured mean grey scale and echogenicity. Standard deviation within the grey scale was redundant, and there was no correlation between the other subjective characteristics and quantitatively measurable values.
 ...
PMID:[Subjective evaluation and quantitative gray-scale analysis in the sonographic diagnosis of diffuse changes in the liver parenchyma]. 301 49

Computer tomography (CT) was performed on 48 patients with uncharacteristic abdominal disturbances. Pathological CT findings were encountered in five patients, namely hepatic steatosis in three patients, liver metastases in one, and occlusion of the inferior vena cava in one. CT may be indicated in patients with uncharacteristic abdominal disorders when other investigations are negative. In some patients the negative result of the CT examination for organic disease was of great importance for the psychiatric approach to these patients' psychosomatic disease. In spite of this, the positive yield of abdominal CT seems to be highest when other less expensive examinations or tests have suggested abnormality of abdominal organs.
 ...
PMID:Computer tomography of the abdomen in patients with uncharacteristic abdominal disturbances. 667 51

Ultrasonography (US) was performed in a prospective study of 48 patients with uncharacteristic abdominal symptoms. All patients had been examined in other hospitals, but no diagnosis had been established. Pathologic US findings were encountered in five patients: fatty liver in two patients, gallstones in one patient, ovarian cyst in one, and liver metastases in another patient. US may be used as a diagnostic approach in patients with uncharacteristic abdominal complaints when conventional X-ray examinations are negative. In patients with psychosomatic disease a negative US result may be of importance in the psychiatric approach to these patients' disease.
 ...
PMID:Abdominal ultrasonography in patients with uncharacteristic abdominal symptoms. 667 76

Focal fatty infiltration of the liver is an entity that may be confused with liver metastasis on computed tomography (CT). The imaging results and medical records of 16 patients with CT appearance suggestive of focal fatty liver were reviewed, three of whom had the simultaneous presence of metastatic liver disease. Focal fatty liver often has a distinctive appearance with CT, usually with a nonspherical shape, absence of mass effect, and a density close to water. Liver metastases are usually round or oval, and unless cystic or necrotic, they have CT attenuation values closer to normal liver parenchyma than water. A radionuclide liver scan almost always resolves any confusion about the differential diagnosis of focal fatty liver: a well defined focus of photon deficiency is due to neoplasm rather than focal fatty infiltration. Sonography sometimes helps to confirm the CT impression, but may be misleading if the diagnosis of focal or diffuse fatty infiltration is not suspected before the examination.
 ...
PMID:CT appearance of focal fatty infiltration of the liver. 697 79

We have measured antibodies to the enterobacterial common antigen (ECA) in sera of 86 patients with various liver diseases. ECA is a component of the cell wall of all enteric bacteria, and ECA antibodies are a specific indication of the presence of enterobacterial components. Patients with alcoholic cirrhosis with or without signs of alcoholic hepatitis had significantly raised anti-ECA titres compared with healthy control subjects. Other groups of patients (alcoholic hepatitis and/or fatty liver, primary biliary cirrhosis, chronic active hepatitis, or liver metastases) did not differ significantly from controls in the height of their anti-ECA titres. The results support the concept that Gram-negative bacterial components may have some role in the pathophysiology of alcoholic cirrhosis.
 ...
PMID:Endotoxin and liver diseases. High titres of enterobacterial common antigen antibodies in patients with alcoholic cirrhosis. 729 16

CT is an important technique in liver imaging. To improve the detection of focal liver lesions the use of non-specific, water-soluble contrast media (CM) is mandatory. However, even with use of these CM the sensitivity in tumour detection is low. In the development of liver-specific CM, the majority of the agents have been targeted to the reticuloendothelial system (RES). The clinical use of RES-specific contrast agents has been hampered by frequent adverse reactions, and a new concept whereby the CM is taken up by the hepatocytes has been developed as an alternative. Such a CM is taken up by normal liver parenchyma but not by tumour cells, enhancing the difference between normal and pathological tissue, and therefore improving the diagnostic sensitivity. In the present investigation, FP 736-03 and FP 736-04, two hepatocyte-specific lipid emulsions, have been studied using animal models. In normal liver parenchyma dose-dependent enhancement was found, whereas in tumour tissue of experimental liver metastases and hepatocellular carcinoma, no enhancement was noted. The virtually unchanged attenuation in tumour tissue meant that the liver-to-lesion contrast increased steadily during the observation period. In an attempt to establish the relationship between enhancement and tumour detection, the accumulated doses of FP 736-04 were used. Increasing accuracy in the diagnosis of liver metastases was found up to an enhancement level of 30 HU. A further increase yielded similar detection rates, but a higher proportion of false-positive results. Comparison with iohexol was rendered difficult by the occurrence of image artefacts when this CM was used. However, FP 736-03 proved superior to both native and iohexol-enhanced CT for detection of hepatic metastases. The efficacy of FP 736-04 was also studied in diseased hepatic parenchyma. In cases of fatty liver infiltration, enhancement by FP 736-04 was significantly reduced as compared with normal controls. The degree of enhancement observed in cirrhotic livers did not differ significantly from that in the controls. These preclinical investigations have shown that the hepatocyte-specific lipid emulsions FP 736-03 and FP 736-04 improve the diagnostic accuracy of focal liver lesions as compared to native and water-soluble CM-enhanced CT. FP 736-04 is taken up by diseased liver parenchyma. However, the detection of malignancy in steatotic and cirrhotic livers has not yet been studied with use of this CM.
 ...
PMID:Hepatocyte-specific contrast media for CT. An experimental investigation. 916 54

The frequency and severity of fatty infiltration of the liver in patients receiving 5-fluorouracil (5-FU) and folinic acid has not been documented systematically. Its development can result in difficulty assessing disease progression, and treatment may be altered inappropriately. Twenty-seven patients with colon cancer and liver metastases receiving 5-FU and folinic acid were studied with computerized tomography (CT) before treatment and after six or 12 cycles of chemotherapy. Forty-seven per cent of patients developed hepatic steatosis during treatment. There was no correlation between development of hepatic steatosis and the dose of chemotherapy or the liver function tests. Hepatic steatosis occurs commonly in patients receiving 5-FU and folinic acid and can be severe. Its development can make hepatic metastases difficult to assess and if its benign nature is not appreciated treatment may be inappropriately altered.
 ...
PMID:Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. 966 83

A 71-year-old woman with liver metastases from colon adenocarcinoma in a severe fatty liver underwent T2-weighted MR imaging with conventional spin-echo (CSE), breath-hold fast-SE (BH-fast-SE), respiratory-triggered fast-SE (RT-fast-SE), and multishot SE echo-planar (SE-EP) techniques. CSE and SE-EP T2-weighted images showed the metastases as areas of high signal intensity. In contrast, RT-fast-SE and BH-fast-SE images showed them as areas of low signal intensity. Metastatic tumors in severe fatty liver can be shown as low signal-intensity areas with T2-weighted MR imaging using fast-SE sequences without use of the fat-suppression technique.
 ...
PMID:Metastases in fatty liver: appearance on conventional spin-echo, fast-spin-echo, and echo-planar T2-weighted MR images. 971 95


1 2 3 Next >>